0001179110-20-003225.txt : 20200306
0001179110-20-003225.hdr.sgml : 20200306
20200306160951
ACCESSION NUMBER: 0001179110-20-003225
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200305
FILED AS OF DATE: 20200306
DATE AS OF CHANGE: 20200306
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GOREVIC JASON N
CENTRAL INDEX KEY: 0001208500
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37477
FILM NUMBER: 20694858
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Teladoc Health, Inc.
CENTRAL INDEX KEY: 0001477449
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
IRS NUMBER: 043705970
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 MANHATTANVILLE ROAD
STREET 2: SUITE 203
CITY: PURCHASE
STATE: NY
ZIP: 10577
BUSINESS PHONE: 2036352002
MAIL ADDRESS:
STREET 1: 2 MANHATTANVILLE ROAD
STREET 2: SUITE 203
CITY: PURCHASE
STATE: NY
ZIP: 10577
FORMER COMPANY:
FORMER CONFORMED NAME: Teladoc, Inc.
DATE OF NAME CHANGE: 20091123
4
1
edgar.xml
FORM 4 -
X0306
4
2020-03-05
0
0001477449
Teladoc Health, Inc.
TDOC
0001208500
GOREVIC JASON N
C/O TELADOC HEALTH, INC.,
2 MANHATTANVILLE ROAD, SUITE 203
PURCHASE
NY
10577
1
1
0
0
Chief Executive Officer
Common Stock
2020-03-05
4
M
0
21812
A
683264
D
Common Stock
2020-03-05
4
F
0
10486
132.73
D
672778
D
Common Stock
2020-03-05
4
M
0
16778
A
689556
D
Common Stock
2020-03-05
4
F
0
8065
132.73
D
681493
D
Performance Stock Units
2020-03-05
4
M
0
21812
0.00
D
Common Stock
21812
43621
D
Restricted Stock Units
2020-03-05
4
M
0
16778
0.00
D
Common Stock
16778
33555
D
Performance stock units convert to shares of TDOC common stock on a one-for-one basis.
Restricted stock units convert to shares of TDOC common stock on a one-for-one basis.
Shares sold to cover the issuer's withholding obligation in respect of reporting person's award.
On February 26, 2020, the reporting person earned 65,433 performance stock units, vesting in three annual installments beginning on March 4, 2020.
On March 4, 2019, the reporting person was granted 50,333 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date.
/s/ Adam C. Vandervoort, attorney-in-fact
2020-03-06